Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular components mediating reactive oxygen species (ROS) generation refers to the collective group of enzymes and organelles that produce ROS as either a primary product or a metabolic byproduct. The most significant enzymatic source is the NADPH oxidase (NOX) family, which includes isoforms like NOX1, NOX2, and NOX4, primarily functioning to generate superoxide and hydrogen peroxide for signaling and host defense (Source: UniProt). Other major contributors include the mitochondrial electron transport chain (Complexes I and III), xanthine oxidase, cytochrome P450 enzymes, and various oxidases in the endoplasmic reticulum and peroxisomes (Source: NIH). While ROS are vital for normal physiological processes such as cell signaling, gene expression, and the immune response, their excessive production leads to oxidative stress and cellular damage (Source: StatPearls). This imbalance is implicated in the pathogenesis of numerous diseases, including atherosclerosis, hypertension, neurodegenerative disorders, and cancer (Source: PubMed). The dual nature of these components is a critical consideration in drug development, as complete inhibition can impair essential signaling and immune functions. For instance, deficiency in the NOX2 complex leads to chronic granulomatous disease, highlighting the necessity of controlled ROS production for pathogen clearance (Source: NIH). Modern therapeutic approaches aim for isoform-specific inhibition or organelle-targeted antioxidants to minimize off-target effects and maintain physiological homeostasis.
Pharmacological agents target these components by inhibiting specific enzymatic activities, such as the competitive inhibition of xanthine oxidase by allopurinol or the isoform-specific inhibition of NADPH oxidases by setanaxib. Other strategies involve the use of mitochondria-targeted molecules that either scavenge ROS at the site of production or modulate electron transport to prevent the leakage of electrons to molecular oxygen (Source: PubMed, PubChem).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular components mediating reactive oxygen species generation.